Related references
Note: Only part of the references are listed.Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes
Ruslan Novosyadlyy et al.
CANCER RESEARCH (2010)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
Sofia Avnet et al.
CANCER RESEARCH (2009)
The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
Fei Huang et al.
CANCER RESEARCH (2009)
Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
Christele Desbois-Mouthon et al.
CLINICAL CANCER RESEARCH (2009)
Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer
Jiping Zha et al.
MOLECULAR CANCER THERAPEUTICS (2009)
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M. Carboni et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
A. Gualberto et al.
ONCOGENE (2009)
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
Apostolos Klinakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Insulin Receptor Expression by Human Prostate Cancers
Michael E. Cox et al.
PROSTATE (2009)
Advances in male contraception
Stephanie T. Page et al.
ENDOCRINE REVIEWS (2008)
IGF and Insulin Receptor Signaling in Breast Cancer
Antonino Belfiore et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Paola Pisani
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts
Vasundara Venkateswaran et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor
Stuart N. Prince et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
The role of insulin receptor isoforms and hybrid Insulin/IGF-I receptors in human cancer
Antonino Belfiore
CURRENT PHARMACEUTICAL DESIGN (2007)
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
Hua Zhang et al.
CANCER RESEARCH (2007)
IGF1R signalling and its inhibition
J. Riedemann et al.
ENDOCRINE-RELATED CANCER (2006)
The use of targeted mouse models for preclinical testing of novel cancer therapeutics
Kenneth P. Olive et al.
CLINICAL CANCER RESEARCH (2006)
Harnessing preclinical mouse models to inform human clinical cancer trials
DH Gutmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Novel human monoclonal antibodies to insulin-like growth factor (IGH)-II that potently inhibit the IGF receptor type I signal transduction function
Y Feng et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas
A Ouban et al.
HUMAN PATHOLOGY (2003)
Loss of IGF2 imprinting:: A potential marker of colorectal cancer risk
HM Cui et al.
SCIENCE (2003)
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
G Pandini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signaling
KR Kalli et al.
ENDOCRINOLOGY (2002)
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis
T Lopez et al.
CANCER CELL (2002)
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer
V Vella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
HM Khandwala et al.
ENDOCRINE REVIEWS (2000)
Share Paper
